Bruns-Garland syndrome in patient with long-term type 2 diabetes
 
More details
Hide details
1
Department of Internal Medicine, Diabetology and Nephrology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Katowice, Poland
 
2
Independent Public Healthcare Centre Provincial Specialist Hospital No. 3 in Rybnik, Poland
 
 
Corresponding author
Edyta Cichocka   

Klinika Chorób Wewnętrznych, Diabetologii i Nefrologii, Wydział Nauk Medycznych w Zabrzu, Śląski Uniwersytet Medyczny w Katowicach, ul. 3 Maja 13, 41-800 Zabrze
 
 
Ann. Acad. Med. Siles. 2024;78:248-252
 
KEYWORDS
TOPICS
ABSTRACT
The Bruns-Garland syndrome (diabetic amyotrophy) is a rare disorder that affects fewer than 1% of patients with diabetes. It is manifested by unilateral or bilateral pain, weakness and muscle wasting in the proximal part of the lower limbs (proximal motor neuropathy). We present a 72-year-old patient with long-term type 2 diabetes mellitus and with the Bruns-Garland syndrome. All the symptoms, including neurological manifestations, were reversible and resolved after the implementation of intensive treatment. Optimizing diabetes treatment, rehabilitation, pain management and the use of benfotiamine and alpha-lipoic acid preparations were crucial to accelerate the treatment effects of diabetic amyotrophy.
REFERENCES (8)
1.
Dyck P.J., Kratz K.M., Karnes J.L., Litchy W.J., Klein R., Pach J.M. et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology 1993; 43(4): 817–824, doi: 10.1212/wnl.43.4.817.
 
2.
Nagsayi S., Somashekhar C., James C.M. Diagnosis and management of diabetic amyotrophy. Endocrinology 2010: 327–329.
 
3.
Dyck P.J., Windebank A.J. Diabetic and nondiabetic lumbosacral radiculoplexus neuropathies: new insights into pathophysiology and treatment. Muscle Nerve 2002; 25(4): 477–491, doi: 10.1002/mus.10080.
 
4.
Llewelyn D., Llewelyn J.G. Diabetic amyotrophy: a painful radiculoplexus neuropathy. Pract. Neurol. 2019; 19(2): 164–167, doi: 10.1136/practneurol-2018-002105.
 
5.
Sobańska A. Diagnostyka różnicowa zaburzeń czucia. Neurol. Dypl. 2013; 8(1): 34–44.
 
6.
Agarwal A., Srivastava M.V.P., Vishnu V.Y. Diabetic amyotrophy (Bruns-Garland syndrome): A narrative review. Ann. Indian Acad. Neurol. 2022; 25(5): 841–844, doi: 10.4103/aian.aian_239_22.
 
7.
Glenn M.D., Jabari D. Diabetic lumbosacral radiculoplexus neuropathy (diabetic amyotrophy). Neurol. Clin. 2020; 38(3): 553–564, doi: 10.1016/j.ncl.2020.03.010.
 
8.
Cohen K., Shinkazh N., Frank J., Israel I., Fellner C. Pharmacological treatment of diabetic peripheral neuropathy. P T 2015; 40(6): 372–388.
 
eISSN:1734-025X
Journals System - logo
Scroll to top